[Action of the new hypocholesteremic agent DH-581 (dithiobisphenol) in humans].
D000328:Adult; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001796:Blood Protein Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D013440:Sulfides / Q000009:adverse effects / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D010636:Phenols; D010919:Placebos; D013440:Sulfides
Acción del nuevo hipocolesterolemizante DH-581 (ditiobisfenol) en humanos.